{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:39:09Z","timestamp":1793324349614,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jchf.2024.04.016","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T14:03:15Z","timestamp":1716991395000},"page":"1257-1269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Autoimmune Disorders in Heart\u00a0Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"12","author":[{"given":"Atsushi","family":"Tada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Ibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-7669","authenticated-orcid":false,"given":"Jwan A.","family":"Naser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Amdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh N.V.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Borlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2024.04.016_bib1","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2024.04.016_bib3","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1093\/cvr\/cvac133","article-title":"Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions","volume":"118","author":"Pugliese","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.jchf.2024.04.016_bib4","first-page":"1549","article-title":"Interleukin-6 in patients with heart failure and preserved ejection fraction","volume":"11","author":"Alogna","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2024.04.016_bib5","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2024.04.016_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/ejhf.2563","article-title":"Sex and central obesity in heart failure with preserved ejection fraction","volume":"24","author":"Sorimachi","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.016_bib7","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.04.016_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2024.04.016_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007495","article-title":"Myocardial microvascular dysfunction in rheumatoid arthritis(quantitation by (13)N-ammonia positron emission tomography\/computed tomography)","volume":"12","author":"Amigues","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2024.04.016_bib11","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure","volume":"69","author":"Mantel","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijcard.2017.03.108","article-title":"Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population","volume":"240","author":"Davis","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/acr.23920","article-title":"Five-year follow-up of coronary microvascular dysfunction and coronary artery disease in systemic lupus erythematosus: results from a community-based lupus cohort","volume":"72","author":"Sandhu","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jchf.2024.04.016_bib14","first-page":"109","article-title":"The implication of tissue Doppler echocardiography and cardiopulmonary exercise in early detection of cardiac dysfunction in systemic lupus erythematosus patients","volume":"3","author":"Elnady","year":"2016","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.jchf.2024.04.016_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cardfail.2018.02.012","article-title":"Impairment of left atrial mechanics is an early sign of myocardial involvement in systemic sclerosis","volume":"24","author":"Porpaczy","year":"2018","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2024.04.016_bib16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/rheumatology\/keu350","article-title":"Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography","volume":"54","author":"Rodriguez-Reyna","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jchf.2024.04.016_bib17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacc.2021.07.014","article-title":"Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC state-of-the-art review","volume":"78","author":"Pandey","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib18","first-page":"294","article-title":"Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem","volume":"12","author":"Upadhya","year":"2015","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.CIR.103.7.967","article-title":"Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis","volume":"103","author":"Ponikowski","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.016_bib20","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00421-019-04222-6","article-title":"Unexplained exertional intolerance associated with impaired systemic oxygen extraction","volume":"119","author":"Melamed","year":"2019","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jchf.2024.04.016_bib22","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1093\/eurheartj\/ehw241","article-title":"Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction","volume":"37","author":"Borlaug","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.04.016_bib23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCULATIONAHA.116.024822","article-title":"Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study","volume":"135","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.016_bib24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ejhf.1902","article-title":"Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.016_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3899\/jrheum.091461","article-title":"Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities","volume":"85","author":"El-Gabalawy","year":"2010","journal-title":"J\u00a0Rheumatol Suppl"},{"key":"10.1016\/j.jchf.2024.04.016_bib26","first-page":"247","article-title":"The epidemiology of Sjogren's syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib27","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","article-title":"Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis","volume":"60","author":"Bairkdar","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jchf.2024.04.016_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/joim.13595","article-title":"Long-term risk of heart failure and other adverse cardiovascular outcomes in primary Sjogren's syndrome","volume":"293","author":"Sun","year":"2023","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jchf.2024.04.016_bib29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1253\/circj.CJ-21-0795","article-title":"Left atrial myopathy in heart failure with preserved ejection fraction","volume":"87","author":"Omote","year":"2023","journal-title":"Circ J"},{"key":"10.1016\/j.jchf.2024.04.016_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.114.001825","article-title":"Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction","volume":"8","author":"Dhakal","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.016_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/CS20160001","article-title":"Hypothalamic and inflammatory basis of hypertension","volume":"131","author":"Khor","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jchf.2024.04.016_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/HYPERTENSIONAHA.110.160671","article-title":"Sympathetic response to insulin is mediated by melanocortin 3\/4 receptors in the hypothalamic paraventricular nucleus","volume":"57","author":"Ward","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jchf.2024.04.016_bib33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ejhf.2093","article-title":"Peripheral and pulmonary effects of inorganic nitrite during exercise in heart failure with preserved ejection fraction","volume":"23","author":"Reddy","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.016_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jacc.2012.02.055","article-title":"Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction","volume":"60","author":"Haykowsky","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/CIRCULATIONAHA.119.045409","article-title":"Altered hemodynamics and end-organ damage in heart failure: impact on the lung and kidney","volume":"142","author":"Verbrugge","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.016_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/CIRCHEARTFAILURE.108.785501","article-title":"Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone","volume":"1","author":"Lewis","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.016_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead106","article-title":"Mortality estimates and excess mortality in rheumatoid arthritis","author":"Black","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jchf.2024.04.016_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/rheumatology\/keaa267","article-title":"Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls","volume":"60","author":"Bultink","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jchf.2024.04.016_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjcard.2013.08.047","article-title":"Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)","volume":"113","author":"Van Tassell","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2024.04.016_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 blockade in patients with heart failure with preserved ejection fraction","volume":"11","author":"Van Tassell","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.016_bib41","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.016_bib42","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.04.016_bib43","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41591-023-02526-x","article-title":"Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial","volume":"29","author":"Borlaug","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2024.04.016_bib44","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/ejhf.2977","article-title":"Rationale and design of ENDEAVOR: a sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction","volume":"25","author":"Lund","year":"2023","journal-title":"Eur J Heart Fail"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924003366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924003366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:15:29Z","timestamp":1782486929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177924003366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2213177924003366"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2024.04.016","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Disorders in Heart\u00a0Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2024.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}